SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Israel Acquisitions Corp (ISRL) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 52/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ISRL
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.22
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$1.89 |
$93.9M |
$5.13M |
5.5% |
| 2015 |
$-4.32 |
$74.51M |
$-11.74M |
-15.8% |
| 2016 |
$0.46 |
$54.94M |
$1.26M |
2.3% |
| 2017 |
$-26.30 |
$65.95M |
$-71.46M |
-108.4% |
| 2018 |
$-5.36 |
$81.34M |
$-14.56M |
-17.9% |
| 2021 |
$0.00 |
$0.00 |
$-5.06K |
- |
| 2022 |
$-0.02 |
$0.00 |
$-71.94K |
- |
| 2023 |
$0.32 |
$0.00 |
$6.07M |
- |
| 2024 |
$0.38 |
$0.00 |
$2.82M |
- |
| 2025 |
$-0.22 |
$0.00 |
$-510.23K |
- |
